Navigation Links
Multi billion-dollar suit filed against cell phone firm for causing brain tumours

In the United States of America, a lawyer- Peter Angelos, who won millions of dollars as compensation from the tobacco industry in Maryland, has announced that he is dragging Vodafone to court in a billion dollar suit. He is claiming compensation to cell phone users who are said to have developed brain tumours after using the instruments made by Verizon wireless. This case has raised eyebrows not only because of the high profile names involved but also because this will be a landmark case whatever be the verdict.

Vodafone has in the meanwhile announced that a British government funded study recently failed to prove that cell phone usage could cause brain tumours. Analysts are quick to point out that though there is no evidence as yet linking cell phone radiation to brain tumours, a spurt of legal battles are expected as more and more cases are detected. The lawyers of the legal firm, which has slapped the case on the cell phone manufacturer, have another version to say. They claim if the manufacturers had known about the harmful effects of the radiation emitted, then these people should be punished severely- they say. Whichever way the case goes, it is sure to open up a Pandora’s box and will also attract world wide attention. Because these days cell phones have become extensions of the human body!!!!!
'"/>




Page: 1

Related medicine news :

1. Naked DNA Vaccination May Conquer Arthritis and Multiple Sclerosis
2. Multiple organ disease cured by genes
3. Gene connected to Multi-System disorder discovered
4. Adult stem cells in treatment for Multiple sclerosis (MS)
5. Multi-Drug Therapy Effective in Lowering Blood Pressure
6. Life Quality For Patients With Multiple Sclerosis
7. Effective Pain Relief For Patients Suffering From Multiple Sclerosis
8. Multi-Drug Therapy Found To Be More Effective in Lowering B.P
9. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
10. Hope For Patients With Multiple Sclerosis
11. Individuals Born In May At A Higher Risk Of Developing Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... , ... March 28, 2017 , ... ... plans work, the Self-Funding Success website has recently developed and published an informational ... Plans ” was created based on common inquiries the site’s team of third ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved ... procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive list ...
(Date:3/28/2017)... ... 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of all ... lot to offer to the discussion of dealing with excess skin oil. “Oily skin is ... home remedies that can help remove the oily shine while keeping the skin fresh and ...
(Date:3/27/2017)... Aurora, CO (PRWEB) , ... March 27, 2017 , ... ... Dr. Mark Braasch for leading sleep apnea treatment, with or without a referral. Sleep ... the condition, which can include daytime sleepiness, morning headaches and chronic snoring. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Biotechnology and ... and engagement over the household brands of Top-20 pharma by optimizing clinical trial ... partnering with the right outsourcing payments provider can provide the technology, infrastructure, and ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
(Date:3/27/2017)... 27, 2017 Summary This ... Eli Lilly and its partnering interests and activities since 2010. ... provides an in-depth insight into the partnering activity of one ... demand company reports are prepared upon purchase to ensure inclusion ... The report will be delivered in PDF format ...
(Date:3/27/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company, announced ... efficacy studies. The company is harnessing the power of ... A, in an effort to find a better treatment ... 4 weeks of treatment in transgenic mice, the lead ... a full toxicology report of various organs. Cytotoxic T-cells ...
Breaking Medicine Technology: